• Home
  • Search Results

Search Results

374 studies match your search
Open

IMVT Batoclimab Efficacy and Safety

The purpose of the current Phase 3 study is to confirm the effectiveness and safety of batoclimab in participants with generalized Myasthenia Gravis in 2 different doses of batoclimab compared to placebo.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Brain, Head, Nervous System
Open

ARFID Genes and Environment

Are you the parent of a child with extreme picky eating or avoidant/restrictive food intake disorder (ARFID)? Are you an adult (18+) who has ARFID? If so, you might be eligible to participate in a research study examining the environmental and genetic factors associated with developing ARFID. Compensation is provided.

Age & Gender
  • 7 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Eating, Nutrition, and Metabolism
  • Mental and Emotional Health
  • and 3 more
Visit Location
100% Remote (online, phone, text)
Open

GLP-1 Survey

Have you taken a GLP-1 agonist drug such as semaglutide for weight loss? You may be able to participate in a research study to find out if taking GLP-1 agonist drugs such as semaglutide have any effect on physical function or quality of life.

Age & Gender
  • 65 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Obesity
Visit Location
100% Remote (online, phone, text)
Open

Treatment-Resistant Depression Study

Have you had depression for at least 3 months? If your depression has not improved with two antidepressants, you may be able to take part in a research study to learn more about psilocybin-assisted therapy.

Age & Gender
  • 18 years ~ 70 years
  • Male, Female, Gender Inclusive
Study Interest
  • Mental and Emotional Health
Open

Phase I Study of Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3 T c

Do you have glioblastoma? Has your cancer either come back or did not improve after the treatments you received? If so, you may be eligible to participate in this gene therapy research study that wants to learn if a new way to modify your immune cells for use as possible treatment is safe and at what dose.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Brain and Other Nervous System, Phase 1 Trials (all cancers))
Open

Brief psychotherapy and non-invasive brain stimulation for depression study

Do you suffer from depression? If so, you may be eligible for a study that provides a brief single session of psychotherapy. This session will provide strategies for managing your depression and may be combined with non-invasive brain stimulation. We are also recording electrical brain activity during a decision-making task. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Mental and Emotional Health
Open

Study of CD30 CAR-T cells for Non-seminomatous Germ Cell Tumors (NSGCT)

Do you have a type of cancer known as Nonseminmatous Germ Cell Tumor (NSGCT)? Has your cancer come back, or not get better with the last treatment you received? If so, you may be able to participate in a gene therapy study to see if we can use your body's own immune cells as a treatment for your NSGCT.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Other Cancers)
Open

Lung Cancer Screening for Current and Former Smokers Study

Are you a current or former smoker who is 50 years or older? You may be able to take part in a research study about lung cancer screening.

Age & Gender
  • 50 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Colorectal, Head and Neck, and 5 more)
  • Healthy Volunteer or General Population
  • Lungs and Breathing
  • Substance Use (tobacco, alcohol, opioids, etc)
Open

Effect of Different Shoes on Walking

Are you interested in how changes in shoes and footwear can be used to make improvements to day-to-day life? You may be able to participate in a research study to quantify the biomechanical effects of different footwear on walking. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Chronic Conditions
  • Healthy Volunteer or General Population
  • and 8 more
Open

FLASH study

Being able to understand and measure communication development in young children is critical. Our team is adapting a tool to measure communication in young children with autism. If you have a young child (under 5 years old) with a diagnosis or suspected diagnosis of autism, you may be able to participate in this study. Compensation provided.

Age & Gender
  • 12 months ~ 60 months
  • Male, Female, Gender Inclusive
Study Interest
  • Developmental
  • Parents of Children
  • Language and Speech
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research